Overview
Hosted by our friends and partners at KPMG, join us for the MedTech Actuator Singapore Origin Oration event, "From Idea to Unicorn".
Whether you have an idea for a health technology innovation, are working on an early-stage health technology startup, or work at an organisation supporting innovation or startups, this event is for you.
Listen to key speakers including:
Prof. Nick Opie, as he talks about the process of taking Synchron - one of the most exciting deep tech companies commercialising a world first brain computer interface - from an idea to a unicorn.
MedTech Actuator Co-Founder & CSO, Prof. Vishaal Kishore, as he shares insight into the Origin program, its history, success, and the opportunity for Singapore.
All superheroes have a beginning. We invite you to join the conversation, learn, network, and celebrate the launch of Origin Singapore!
Origin Singapore: Building a diverse pool of healthtech startups in Singapore
What is Origin?
Origin is a 3-month intensive venture builder program that has over the last 10 years developed the entrepreneurial capabilities of over 2,500 clinicians, researchers, engineers, scientists, students, and inventors, and supported the creation of 120 startups - including a unicorn - that have gone on to raise more than A$750m of capital.
Schedule
Date: 01 Jul 2024, Monday
Time: 6:30 PM - 8:30 PM (GMT +8:00) Kuala Lumpur, Singapore
Location: KPMG Clubhouse, 12 Marina View #15-00 Singapore, 018961
Speakers
Speaker's Profile:
Vishaal Kishore, Co-founder, CSO, MedTech Actuator
Dr Vishaal Kishore is an expert in health system innovation and transformation. He is also a Professor of Innovation & Public Policy at RMIT University where he leads the pathbreaking RMIT-Cisco Health Transformation Lab. He regularly advises governments, NGOs and corporates in respect of strategy, public policy and innovation. Holding a doctorate from Harvard University, Vishaal has served as Deputy Secretary at the Department of Health & Human Services; Director for government strategy within EY’s management consulting practice; and an M&A lawyer at Mallesons and Freehills.
